Four metabolic pathways have been identified in vivo, none of which accounted for more than 6.5% of the dose: dealkylation, hydroxylation, dehydrogenation, and benzisoxazole scission.
In vivo on kindlaks tehtud neli metaboolset rada, millest ükski ei hõlmanud üle 6, 5% annusest: dealküülimine, hüdroksüülimine, dehüdrogeenimine ja bensisoksasooli lõhustamine.